|
PTPDC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52829970900825E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85484960724125E-12 |
| Normal-vs-Stage2 |
4.21910000000247E-05 |
| Normal-vs-Stage3 |
8.084700E-03 |
| Normal-vs-Stage4 |
3.007900E-02 |
| Stage1-vs-Stage2 |
9.358000E-01 |
| Stage1-vs-Stage3 |
3.677700E-03 |
| Stage1-vs-Stage4 |
3.004900E-03 |
| Stage2-vs-Stage3 |
4.291800E-02 |
| Stage2-vs-Stage4 |
2.051600E-02 |
| Stage3-vs-Stage4 |
7.559600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.88999993012385E-11 |
| Normal-vs-AfricanAmerican |
9.767800E-04 |
| Normal-vs-Asian |
2.140300E-02 |
| Caucasian-vs-AfricanAmerican |
9.075600E-01 |
| Caucasian-vs-Asian |
1.450220E-01 |
| AfricanAmerican-vs-Asian |
1.139360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.89390000641055E-09 |
| Normal-vs-Female |
1.19260001874011E-09 |
| Male-vs-Female |
4.084200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.685750E-01 |
| Normal-vs-Age(41-60Yrs) |
1.17109988373443E-10 |
| Normal-vs-Age(61-80Yrs) |
5.23750000036571E-07 |
| Normal-vs-Age(81-100Yrs) |
1.232230E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.261450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.235600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.528000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.922000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.783400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.902400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.739920E-03 |
| Normal-vs-Grade 2 |
2.36055619495801E-12 |
| Normal-vs-Grade 3 |
1.09729999997477E-06 |
| Normal-vs-Grade 4 |
5.239800E-01 |
| Grade 1-vs-Grade 2 |
4.002500E-02 |
| Grade 1-vs-Grade 3 |
7.996300E-03 |
| Grade 1-vs-Grade 4 |
2.953400E-04 |
| Grade 2-vs-Grade 3 |
4.497500E-02 |
| Grade 2-vs-Grade 4 |
4.29000000000679E-05 |
| Grade 3-vs-Grade 4 |
1.117570E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62614366416847E-12 |
| Normal-vs-ccB subtype |
1.924310E-03 |
| ccA subtype-vs-ccB subtype |
1.217340E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.92940000035102E-08 |
| Normal-vs-N1 |
6.671400E-01 |
| N0-vs-N1 |
3.084000E-02 |
|
|
